We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 2.87% | 447.50 | 440.00 | 455.00 | 452.50 | 435.00 | 435.00 | 148,441 | 14:52:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0936 | 47.81 | 207.28M |
From Nov 2022 to Nov 2024
TIDMTSTL
RNS Number : 6547B
Tristel PLC
05 June 2023
Tristel plc
("Tristel" or the "Company")
Analyst and Investor presentation
Re. news of FDA De Novo approval for Tristel ULT as a high level disinfectant
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will hold a presentation for analysts and investors following this morning's announcement that Tristel ULT was approved by the FDA as a high level disinfectant for use on endocavity ultrasound probes and skin surface transducers.
Paul Swinney , CEO, and Liz Dixon, CFO, will provide details of the Company's North America Commercial Strategy in a presentation which is open to all existing and potential shareholders, as well as analysts.
The live presentation will take place on the Investor Meet Company platform at 4.30pm today, Monday 5 June 2023, and a replay facility will also be available shortly afterwards. Questions can be submitted at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Tristel plc to register for the presentation via: https://www.investormeetcompany.com/tristel-plc/register-investor
For further information please contact:
Tristel plc Tel: 01638 721 500 Paul Swinney, Chief Executive Officer Liz Dixon, Chief Financial Officer Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Applegarth Mob: 07584 391 303 finnCap Tel: 020 7220 0500 Geoff Nash/ Charles Beeson (Corporate Finance) A lice Lane (ECM)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFIFETRTIEIIV
(END) Dow Jones Newswires
June 05, 2023 05:00 ET (09:00 GMT)
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
